NCT05634785 2026-01-09CD30 CAR for CD30+ NSGCTUNC Lineberger Comprehensive Cancer CenterPhase 2 Completed2 enrolled
NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA